Christopher Podgorski, MD

Washington University/B-JH/SLCH Consortium
Maplewood, MO, United States

Internal Medicine Residency and Internship: University of Minnesota, Minneapolis, MN, USA (2019-2022)

Disclosure information not submitted.

Presentation(s):

• L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders

  Monday, November 14, 2022
  2:05 PM – 2:10 PM Eastern Time